Klow

About Klow

Klow combines KPV (an α-MSH fragment with potent anti-inflammatory activity) with GHK-Cu (the copper-bound skin-remodeling tripeptide) and additional repair-phase actives. The combination targets both the inflammatory signal and the downstream repair cascade. The blend logic: KPV silences NF-κB-driven inflammation before it damages the tissue matrix. GHK-Cu then drives collagen synthesis and copper-dependent repair enzymes. Treating both phases lets researchers study dermal recovery end-to-end rather than one window at a time. IF the research question is multi-phase skin or barrier recovery, THEN Klow addresses both the inflammatory and reconstructive windows in a single formulation. SO it fits in studies examining post-injury skin remodeling, barrier integrity, or compound anti-inflammatory endpoints. Each active independently verified.

Specifications

Purity

>99% HPLC

Form

Lyophilized powder

Storage

Store at 2–8°C